Wipro Ltd. News and Updates

Name: Latest research reports of Wipro Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Wipro Ltd.
Rating: 3
Author: Motilal Oswal

Keep track of all breaking news on Wipro Ltd. from all sources in a single place.

Load latest

Wipro Ltd.

17 Jan 2025

251.57

-2.22%

Wipro Results Earnings Call for Q3FY25

Conference Call with Wipro Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Wipro Ltd.

17 Jan 2025

251.57

-2.22%

to see Rapid results content

Wipro Ltd.

17 Jan 2025

251.57

-2.22%

Steady with little surprises

Neutral: Wipro Ltd.

Motilal Oswal

Wipro (WPRO) reported 3QFY25 IT Services revenue of USD2.6b (0.1% QoQ) in constant currency (CC), above our estimate of a 1.0% QoQ decline. It posted an order intake of USD3.5b (down 1.3% QoQ), with a large deal TCV of USD0.96b (down 35% QoQ).

Wipro Ltd. is trading below its 50 day SMA of 258.8

Wipro Ltd.

08 Jan 2025

251.57

-2.22%

Wipro Q3FY25 preview: Analysts expect muted growth

Business Line

In Q2, Wipro's EBIT margins were 16.8 per cent. Brokerages expect a drop to 16.4 per cent this quarter.

Wipro Ltd. has an average target of 252.86 from 10 brokers.

Wipro Ltd.

07 Jan 2025

251.57

-2.22%

Wipro Q3 Results: Announcement Date, Dividend News And Other Key Details

NDTV Profit

Over the past week, shares of Wipro Ltd. have fallen 3.18%. The stock opened flat at Rs 294.30 on Tuesday on the NSE.

Wipro Ltd. is trading above its 30 day SMA of 247.1

Wipro Ltd.

06 Jan 2025

251.57

-2.22%

Wipro veteran quits for CEO role at smaller firm

livemint

Wipro faces yet another leadership shakeup as senior executives opt for agile, high-growth firms. Srini Rajamani's move to a US-based fintech highlights the growing appeal of specialized roles outside traditional IT giants.

Wipro Ltd. is trading above its 30 day SMA of 247.1

Wipro Ltd.

05 Jan 2025

251.57

-2.22%

Blending startup agility with legacy firm's expertise

Business Line

How Wipro Consumer Care Ventures mentors innovative young businesses

Wipro Ltd. has an average target of 252.86 from 10 brokers.

Wipro Ltd.

02 Jan 2025

251.57

-2.22%

Former Wipro- GE HealthCare MD to head Claypond Capital's MedTech platform

Business Line

He will oversee strategy and execution, with the platform focusing on developing medical equipment and digital solutions for both domestic and export markets

Wipro Ltd. is trading below its 50 day SMA of 258.8

Wipro Ltd.

30 Dec 2024

251.57

-2.22%

Wipro's Deadline For Applied Value Tech Acquisition Pushed To January

NDTV Profit

Applied Value Technologies Pte is headquartered in Singapore and the acquisition was announced earlier this month.

Wipro Ltd. is trading above its 30 day SMA of 247.1

Wipro Ltd.

28 Dec 2024

251.57

-2.22%

AI moves beyond hype to reality at scale, set to deliver biz value by 2025

Business Standard

Artificial intelligence (AI) transitioned from a temporary trend to a widespread reality, gaining traction across industries due to its potential to enhance efficiency, generate revenue and create entirely new roles, yet concerns around its use and impact on jobs remained. Gone are the days when it was merely a buzzword; AI has now become an integral part of business strategy across various sectors. But its full impact on jobs is little known and so is the issue of intellectual property, data ownership and its privacy implications, and liability - who is liable if an accident or mishap occurs due to the use of AI. As technology becomes increasingly human-like and pervasive, organisations are now striving to unlock business value through innovative methods to engage customers and employees, enhance operational efficiencies, and generate new revenue streams, Wipro CIO Anup Purohit said. "We are working towards a future where AI is integrated seamlessly into everyday operations beyond

Wipro Ltd. has an average target of 252.86 from 10 brokers.

Is Wipro Ltd. worth buying?

4957 Votes:

Buy 71.43%

Sell 10.09%

Hold 18.48%

RESEARCH REPORTS

Accumulate SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf